CD8A and neoplasm: The restored anti-tumor immunity is largely mediated through the reactivation of cluster of differentiation 8 positive (CD8+) cytotoxic T lymphocytes (CTLs) and the enhanced phagocytic function of antigen-presenting cells (APCs)[9].